Main > ONCOLOGY (**) > Leukemia>Lymphocytic>Chronic *** > Treatment > CH. R. ObinutuzuMAb+***



CH. R. ObinutuzuMAb+***'s subsections
(*) EU Approval Date: 2014. 07.29
(*) USA Approval Date: 2013. 11.01
+Chlorambucil
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2017. 08.29
TradeMark (EU)
TradeMark (USA)
TradeMark (USA) Web-Site

CH. R. ObinutuzuMAb+***'s products
This section has no products